At the heart of Smart Health is delivering the right treatment to the right patient at the right time, that is faster, better and more personalized healthcare. But what are the prerequisites for Smart Health, and the benefits to the patients, the European healthcare systems and the societies?
Smart Health is not here yet. A functioning, collaborative Smart Health ecosystem could create not only more health but also more economic wellbeing for our continent.
Smart Health for Europe offers health system decision makers a platform to explore the future health ecosystems.
The event is free of charge. In addition, it will be streamed online.
The topics of the event are related to shaping the future of healthcare:
Smart Health stakeholders are warmly welcome to join the event and network with fellow scientists, healthcare leaders and decision makers, members of the Finnish and the European parliaments, biobanks and national centers of excellence, civil servants, MedTech, HealthTech and pharmaceuticals industry, and European and local innovators and investors.
Current development in healthcare builds on technology and data, but these are not enough to reach Smart Health goals. Finland showcases a pioneering combination:
The Finnish EU Presidency 2019 is the time to start creation of a Smart Health roadmap. During the coming years, Europe has the potential to move towards a world leading position in digital healthcare and precision medicine driven healthcare and health systems.
Public Affairs Kirsi Heikola, Novartis Finland, +358 40 7290801, email@example.com
Communication Manager Sanna Melin, Novartis Finland, +358 40 1836321, firstname.lastname@example.org
Dr. Arho Virkki is Head of Clinical Informatics at Auria Clinical Informatics, and an Adjunct Professor at Department of Mathematics and Statistics at the University of Turku.
His research interests include machine learning, data mining and mathematical modeling for decision support. At Auria, his key goals include providing researchers and specialists with high-quality patient data in pseudonymized or anonymized format to facilitate the development of data-informed approaches to precision medicine and safe, cost-effective treatment strategies.
Professor Dr. Hartwig Huland is the senior physician at the Prostate Centre at the Hamburg Eppendorf University Clinic. He founded this specialist clinic together with Professor Dr. Markus Graefen in 2005.
Professor Huland is a guest speaker in the 2019 edition of Harvard Business School's Intensive Course on Value Based Healthcare course.
Head Global Data Privacy, Novartis
Knut Mager is Novartis’ Head Global Data Privacy and a member of the Advisory Board of the Future of Privacy Forum (FPF) and the Centre for Information Policy Leadership Advisory Council (CIPL). From April 2016 to June 2019, Knut chaired the Data Protection working group of European Federation of Pharmaceutical Industries and Associations (EFPIA).
Knut joined Novartis in 2003 as General Counsel, Head of Legal of the Sandoz Division. Since 2007, he held various leadership positions with Novartis Group Legal, inter alia Head of Commercial Legal and Head Country Legal Organizations.
Knut started his career in 1990 at Schering AG (now Bayer) in Berlin, Germany, where he held various positions including Head of Patents and Head Corporate Strategy. He is a German attorney-at-law (Rechtsanwalt) and INSEAD certified international director (IDP-C).
Head of EU Affairs, VTT Technical Research Centre of Finland
Dr. Leena Sarvaranta is Head of EU Affairs at VTT since 2007. VTT is a fully state-owned, non-profit research organization with a specific public service mandate from the Finnish Ministry of Economic Affairs and Employment. VTT engages in active cooperation between various stakeholders.
Leena’s work is future-oriented and guided by strategic alignment of VTT actions for achieving sustainability and competitiveness at a national as well as the EU level through collaboration in research and innovation activities. Today, VTT is among the most active European research organizations participating in the EU research programmes. VTT is an active member of EARTO, European Association of Research and Technology Organisations, and takes part in constructive dialogue with European institutions, examining issues in a broad innovation policy context across traditional sectoral and administrative boundaries.
In 2014-2018, Leena served in the Strategic Research Council within the Academy of Finland, a funding mechanism for long-term research to support decision-making across society. As a member of the Government Foresight Group in 2016-2019, she took part in coordination of national foresight efforts. She also works in a coordination group for Smart Specialisation Strategy of Helsinki-Uusimaa Region.
Leena has contributed to various EU-level initiatives, more recently the Strategic Forum for Important Projects of Common European Interest (2018-2019). Her earlier activities include High Level Groups on Key Enabling Technologies (2010-2011, 2013-2015) as well as assessments of Contractual PPPs in FP7 and H2020.
Born with rare skin disease, ichtyosis, Silja Lindqvist met the first other person with a similar skin disease at the age of 18. She has been a voluntary worker for raising the awareness of rare diseases and ichtyosis as part of the Finnish Ichtyosis association actions. Silja is a founding member of the European Ichtyosis Network (ENI) and Board member in Allergy, Skin and Asthma Federation of Finland. She has a professional background as a programme manager related to digital services and data.
Since April 2019 Policy Advisor, Unit 511 “New technologies and data use”, Federal Ministry of Health
2017-2019 Policy Advisor, Unit 521 “Strategic issues relating to the national eHealth infrastructure agency (gematik), the eHealth infrastructure and eHealth”, Federal Ministry of Health
2014-2017 Policy Advisor for a member of the Deutsche Bundestag
2005-2011 M.A. Art History, History and Literature (Münster, Florence, Würzburg)
PhD in Biometrics, Director of Social and Health Data Permit Authority Findata
Johanna Seppänen works as director of the newly founded Finnish Social and Health Data Permit Authority Findata with the aim to institute the new authority and its functions.
She has previous positions as Head of Statistics at Statistics Finland Research Services, Head of Statistics and Health Economics at FIOH, Researcher at The Finnish Institute for Health and Welfare, The Social Insurance Institution of Finland Kela Research department and the Finnish Cancer Registry, and as Biostatistician in the pharmaceutical industry. Seppänen has also worked as a Lecturer at the University of Jyväskylä.
Johanna Seppänen is a strong professional with a PhD focused in Biometrics from the University of Helsinki, Faculty of Medicine. She is an experienced leader with track record of leading and developing public sector research infrastructures. Seppänen is skilled in register-based research, statistical methods and biostatistics, data management and lecturing. Her expertise also includes leadership, data protection and research ethical issues.
Johanna Seppänen has 15 peer reviewed articles in international journals and 11 other publications. She is a member of National Committee on Medical Research Ethics.
Senior Director, Health and Wellbeing Ecosystems
Business Finland Oy
Minna Hendolin has been part of the health sector research, innovation and business ecosystem in multiple roles during the last 25 years. Starting from the academic research, continuing to commercialization of own research findings all the way up to the listed multinational biopharmaceutical company and global innovation policy. She has several years of experience in management and leadership both in SMEs and large corporations as well as in public organization. Since 2010, Dr. Hendolin has been working as a health and life science executive for government funding and innovation organizations, first at Tekes and later at Business Finland. At her current position as a Senior Director, she is leading the Health and Wellbeing thematic area at Business Finland covering innovation and export programs, international collaboration, funding and national strategic initiatives and policies. Dr. Hendolin belongs to the World Economic Forum Expert Group and is a member and speaker in Horasis Global Leaders Summit. Ms. Hendolin holds a doctoral degree in biochemistry and molecular biology.
Business Finland is the Finnish innovation funding, trade, investment, and travel promotion organization, headquartered in Helsinki. Business Finland is fully owned by the Finnish Government employing some 600 experts in 40 offices globally and in 20 regional offices around Finland. Business Finland is part of the Team Finland network. www.businessfinland.com